Simon Quick Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$276K Buy
+1,432
New +$154K 0.01% 380
2024
Q3
– Sell
-1,820
Closed -$216K – 449
2024
Q2
$216K Buy
+1,820
New +$230K 0.02% 353
2022
Q2
– Sell
-59
Closed -$10K – 320
2022
Q1
$10K Buy
59
+3
+5% +$505 ﹤0.01% 302
2021
Q4
$14K Sell
56
-34
-38% -$9.9K ﹤0.01% 303
2021
Q3
$34K Buy
90
+20
+29% +$7.38K 0.01% 289
2021
Q2
$16K Sell
70
-500
-88% -$89.4K ﹤0.01% 350
2021
Q1
$74K Sell
570
-1,000
-64% -$145K 0.02% 177
2020
Q4
$164K Buy
1,570
+70
+5% +$7.08K 0.05% 117
2020
Q3
$106K Sell
1,500
-1,500
-50% -$105K 0.03% 126
2020
Q2
$193K Buy
3,000
+1,500
+100% +$82.1K 0.07% 84
2020
Q1
$45K Buy
+1,500
New +$34.5K 0.02% 195

Other funds holding MRNA

Simon Quick Advisors's MRNA Position: Q3 2026 in Review

Simon Quick Advisors opened a new position in Moderna (MRNA) in Q3 2026: 1,432 shares worth $276K. The stake represents 0.01% of the portfolio and ranks #380 among its holdings. This is a return to the name: Simon Quick Advisors previously reported a position in MRNA as recently as Q2 2024.

Simon Quick Advisors first reported a position in MRNA in Q1 2020 and has held it in 11 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Simon Quick Advisors held 1,432 shares of Moderna worth $276K as of Q3 2026.
  • Moderna was a new Simon Quick Advisors position in Q3 2026.
  • Moderna made up 0.01% of Simon Quick Advisors's portfolio in Q3 2026, its #380 holding.
  • Simon Quick Advisors first reported a position in Moderna in Q1 2020 and has held it in 11 quarters since.
  • 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Simon Quick Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.